Hikal profit and loss

Latest FY26
Revenue
₹1,713cr−7.9% on FY25
EBITDA
₹220cr−32.9% on FY25
Net profit
−₹48.8cr₹90.8 cr in FY25
EPS
−₹3.96₹7.36 in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,7351,7131,8601,7852,023
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
13.112.35.02.55.4
1,7481,7251,8651,7872,028
Expenses
8117998838051,122
−53.1−36.9−45.319.5−14.6
282270247247222
59.962.175.256.448.1
167164134118109
463460447446436
1,7301,7181,7411,6921,923
232220328267257
65.256.6194149148
Profit
18.46.812495.5105
−76.2−85.10.00.00.0
−57.8−78.312495.5105
−2.0−2.030.028.430.5
−22.0−27.53.0−2.5−3.5
−24.0−29.533.025.927.0
−33.8−48.890.869.678.4
−33.8−48.890.869.678.4
−1.8−2.4−1.4−0.6−0.6
−35.6−51.289.469.077.8
——90.869.6—
Per share
−₹2.74−₹3.96₹7.36₹5.64₹6.36
−₹2.74−₹3.96₹7.36₹5.64₹6.36
Other comprehensive income — detail
−1.8−2.4−1.4——
———−0.8−0.8
2.53.21.9——
———−0.2−0.2
−0.7−0.8−0.5——
———69.6—
Per share — as-filed variants
−₹2.74−₹3.96₹7.36₹5.64₹6.36
−₹2.74−₹3.96₹7.36₹5.64₹6.36
Derived — gross profit (revenue − materials − purchases − Δ inventories)
9789511,023960916
56.3%55.5%55.0%53.8%45.3%
Adjusted (ex-exceptional items) — derived
18.46.812495.5105
−76.2−85.10.00.00.0
10.84.290.869.678.4
₹0.87₹0.34₹7.36₹5.64₹6.36
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HIKAL₹202.10

Hikal Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersPANACEABIODCALSAIPARENTINDOCOSOLARAWINDLASINDSWFTLABHESTERBIOMcap ₹2,496 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations2,023.01,784.61,859.81,712.61,735.0
Other Income5.42.55.012.313.1
Total Income2,028.41,787.11,864.81,724.91,748.1
Expenses
+ Cost of Materials Consumed1,121.6805.2882.6798.6810.6
+ Changes in Inventories-14.619.5-45.3-36.9-53.1
+ Employee Benefit Expense222.4246.5247.1270.3281.8
+ Finance Costs48.156.475.262.159.9
+ Depreciation & Amortisation109.0117.6134.4163.8167.1
+ Other Expenses436.5446.4447.0460.2463.4
Total Expenses1,923.11,691.61,741.01,718.11,729.7
EBITDA257.1267.0328.4220.4232.3
EBIT148.1149.4194.056.665.2
Profit
PBT before Exceptional Items105.495.5123.86.818.4
+ Exceptional Items0.00.00.0-85.1-76.2
Pretax Income105.495.5123.8-78.3-57.8
+ Current Tax30.528.430.0-2.0-2.0
+ Deferred Tax-3.5-2.53.0-27.5-22.0
Tax Expense27.025.933.0-29.5-24.0
Net Income78.469.690.8-48.8-33.8
+ Net Income — Continuing Ops78.469.690.8-48.8-33.8
+ Other Comprehensive Income-0.6-0.6-1.4-2.4-1.8
Total Comprehensive Income77.869.089.4-51.2-35.6
Net Income to Common—69.690.8——
Per Share
Basic EPS6.365.647.36-3.96-2.74
Diluted EPS6.365.647.36-3.96-2.74
Other Comprehensive Income — detail
+ Other Comprehensive Income——-1.4-2.4-1.8
+ Items NOT to be Reclassified to P&L-0.8-0.8———
+ Tax on Items NOT to be Reclassified——1.93.22.5
+ Tax on Items NOT to be Reclassified — alt tag-0.2-0.2———
+ Tax on Items to be Reclassified——-0.5-0.8-0.7
Comprehensive Income — Owners of Parent—69.6———
Per Share — as-filed variants
Basic EPS — Continuing Operations6.365.647.36-3.96-2.74
Diluted EPS — Continuing Operations6.365.647.36-3.96-2.74
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit916.0959.91,022.5950.9977.5
Gross Margin %45.2853.7954.9855.5256.34
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)105.495.5123.86.818.4
− Exceptional Items (reconciliation)0.00.00.0-85.1-76.2
Net Income Adj (tax-effected)78.469.690.84.210.8
EPS Adj6.365.647.360.340.87
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.00
Filed Debt Equity0.000.000.590.560.53
Filed Dscr0.000.001.451.221.23
Filed Iscr0.000.004.003.763.82
Paid Up Equity Capital24.724.724.724.724.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.